微血管游离组织移植与人工耳蜗:病例系列及文献综述
结果显示MVFTT可用于处理晚期装置外露、骨放射性坏死及肿瘤术后重建,对重度至极重度感音神经性聋患者可考虑在原发肿瘤手术同期行CI。
要点
- MVFTT可用于功能外露CI的修复,避免装置取出。
- 晚期装置外露者可行MVFTT而不必取出装置或行局部修复。
- 侧颞骨或头皮肿瘤术后MVFTT同期可考虑CI。
核心结论
- MVFTT是功能外露人工耳蜗患者的重要重建工具。
- 对重度至极重度感音神经性聋患者,原发肿瘤手术及侧颞骨或头皮MVFTT同期应考虑人工耳蜗植入。
研究设计与样本
- 对MEDLINE进行关键词检索以复习MVFTT在CI患者中的文献。
主要发现
- 1例因晚期装置外露行MVFTT,听力参数稳定,未行局部重建或装置取出。
- 1例因局部晚期鳞状细胞癌行侧颞骨切除术(LTBR)及MVFTT,同期行初次人工耳蜗植入,伴重度感音神经性聋。
- 文献复习提示MVFTT可用于晚期装置外露、骨放射性坏死治疗及原发肿瘤术后重建。
临床怎么用
- 对功能外露的CI患者,MVFTT可作为避免装置取出的重建选择。
- 侧颞骨或头皮肿瘤需MVFTT重建且伴重度至极重度感音神经性聋时,可考虑同期CI。
局限性
- 证据级别为IV级。
- 样本量小(2例),为单机构回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The use of microvascular free tissue transfer (MVFTT) for defects of the scalp and lateral temporal bone in patients with cochlear implants (CI) is uncommon. Herein, we report our experience with the utility, indications, and outcomes for MVFTT in patients with cochlear implants. METHODS: A retrospective review of patients at our institution from September 2016 to December 2017 identified subjects with coexistent cochlear implant and ipsilateral MVFTT of the lateral temporal bone or scalp. Information including demographics, indication for MVFTT, timing of CI and MVFTT, donor site, and previous radiation to the head and neck was collected. To assess the current literature on MVFTT in CI patients, a MEDLINE search was performed using key search terms. RESULTS: Two patients with cochlear implants and MVFTT of the ipsilateral temporal bone or scalp were identified. One patient underwent MVFTT for advanced device extrusion with stable audiometric parameters rather than locoregional reconstruction or device explantation. The second patient had primary cochlear implantation at oncologic lateral temporal bone resection (LTBR) and MVFTT for locally advanced squamous cell carcinoma and concurrent profound sensorineural hearing loss (SNHL). A literature review identifies MVFTT as an option for advanced device extrusion, treatment of osteoradionecrosis, and reconstruction after primary oncologic surgery. CONCLUSION: MVFTT is an important reconstructive tool for patients with functional, exposed cochlear implants. Cochlear implantation for severe to profound SNHL should be considered at the time of primary oncologic surgery and MVFTT of the lateral temporal bone or scalp. LEVEL OF EVIDENCE: IV Laryngoscope, 130:1552-1557, 2020.
引用
- Lindquist NR, Vinh DB, Appelbaum EN, et al. Microvascular free tissue transfer and cochlear implants: A case series and literature review. Laryngoscope. 2019. PMID: 31654455. doi:10.1002/lary.28300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。